Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 31, 2001 - Issue 2
105
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Species difference in stereoselective involvement of CYP3A in the mono-N-dealkylation of disopyramide

, , &
Pages 73-83 | Published online: 22 Sep 2008

References

  • BROGDEN, R. N. and TODD, P. A., 1987, Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias. Drugs, 34, 151–187.
  • COOK, C. S., KARIM, A. and SOLLMAN, P., 1982, Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog. Drug Metabolism and Disposition, 10, 116–121.
  • CUSIC, J. W. and SAUSE, H. W., 1965, 4-Dipropylamino-2-aryl-2-pyridyl-alkanamides. United States Patent, 3, 225,054.
  • ECHIZEN, H., MOCHIZUKI, K., TANI, M. and ISHIZAKI, T., 1994, Interspecies differences in enantio-selective mono -N-dealkylation of disopyramide by human and mouse liver microsomes. Journal of Pharmacology and Experimental Therapeutics, 268, 1518–1525.
  • GIACOMINI, K. M., NELSON, W. L., PERSHE, R. A., VALDIVIESO, L., TURNER-TAMIYASU, K. and BLASCHKE, T. F., 1986, In vivo interaction of the enantiomers of disopyramide in human subjects. Journal of Pharmacokinetics and Biopharmaceutics, 14, 335–356.
  • HEEL, R. C., BROGDEN, R. N., SPEIGHT, T. M. and AVERY, G. S., 1978, Disopyramide: A review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. Drugs, 15, 331–368.
  • KARIM, A., RANNEY, R. E. and KRAYCHY, S., 1972, Species differences in the biotransformation of a new antiarrhythmic agent. Journal of Pharmaceutical Sciences, 61, 888–893.
  • LE CORRE, P., GIBASSIER, D., SADO, P. and LE VERGE, R., 1992, Human pharmacokinetics and metabolism of disopyramide enantiomers. Laboratoire de Pharmacia Galenique et Biopharmacie, Université de Rennes I, France, 4, 80–83.
  • LE CORRE, P., MALLEDANT, Y., CHEVANNE, F., SADO, P. and LE VERGE, R., 1991, Stereoselective biliary elimination of disopyramide and mono-N-desisopropyldisopyramide in humans. Labor atoire de Pharmacia Galenique et Biopharmack, Universite de Rennes I, France, 3, 233–237.
  • LIMA, J. J., BOUDOULAS, H. and SHIELDS, B. J., 1985, Stereoselective pharmacokinetics of disopyramide enantiomers in man. Drug Metabolism and Disposition, 13, 572–577.
  • PAULSON, S. K., ENGEL, L. C., REITZ, B., BOLTEN, S., BURTON, E. G., MAZIASZ, T. J., YAN, B. and SCHOENHARD, G. L., 1999, Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib. Drug Metabolism and Disposition, 27, 1133–1142.
  • SZKLARZ, G. D. and HALPERT, J. R., 1998, Molecular basis of P450 inhibition and activation, implications for drug development and drug therapy. Drug Metabolism and Disposition, 26, 1179–1184.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.